OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALUF55

Alufluoride Ltd

Commodity ChemicalsVerified

Alufluoride Ltd maintains a relatively strong liquidity position, with a current ratio of 2.66, indicating that its current assets significantly exceed its current liabilities. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. The company's debt-to-equity ratio of 0.3 suggests a conservative capital structure, with equity financing playing a dominant role in its capital base. In terms of profitability, Alufluoride Ltd reports a return on equity (ROE) of 6.31% and a return on assets (ROA) of 4.16%. These figures are below the typical thresholds for high-performing companies in the Commodity Chemicals industry, suggesting that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and industry-specific risks. Looking ahead, Alufluoride Ltd is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's capital expenditures are expected to remain in line with historical trends, with a focus on maintaining and upgrading existing production facilities. The company's risk profile is characterized by moderate liquidity risk and low dilution risk. The primary liquidity concern is the negative net cash position after accounting for total debt, which could limit the company's ability to fund operations or pursue growth opportunities without external financing. The low dilution risk is supported by the absence of significant share issuance activity and a stable number of shares outstanding. Recent filings and transcripts indicate that Alufluoride Ltd has not disclosed any material events or strategic initiatives that would significantly impact its financial performance or operational outlook. The company's management has not provided guidance on new product launches, market expansion, or major capital projects.

30-day price · ALUF+125.10 (+30.0%)
Low$392.50High$610.85Close$542.50As of12 May, 00:00 UTC
Profile
CompanyAlufluoride Ltd
TickerALUF.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Alufluoride Ltd is a chemical manufacturing company that produces and sells fluorine-based chemicals, primarily used in the production of aluminum and other industrial applications.

Classification. Alufluoride Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Alufluoride Ltd maintains a relatively strong liquidity position, with a current ratio of 2.66, indicating that its current assets significantly exceed its current liabilities. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. The company's debt-to-equity ratio of 0.3 suggests a conservative capital structure, with equity financing playing a dominant role in its capital base. In terms of profitability, Alufluoride Ltd reports a return on equity (ROE) of 6.31% and a return on assets (ROA) of 4.16%. These figures are below the typical thresholds for high-performing companies in the Commodity Chemicals industry, suggesting that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and industry-specific risks. Looking ahead, Alufluoride Ltd is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's capital expenditures are expected to remain in line with historical trends, with a focus on maintaining and upgrading existing production facilities. The company's risk profile is characterized by moderate liquidity risk and low dilution risk. The primary liquidity concern is the negative net cash position after accounting for total debt, which could limit the company's ability to fund operations or pursue growth opportunities without external financing. The low dilution risk is supported by the absence of significant share issuance activity and a stable number of shares outstanding. Recent filings and transcripts indicate that Alufluoride Ltd has not disclosed any material events or strategic initiatives that would significantly impact its financial performance or operational outlook. The company's management has not provided guidance on new product launches, market expansion, or major capital projects.
Key takeaways
  • Alufluoride Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating a strong reliance on equity financing.
  • The company's return on equity (6.31%) and return on assets (4.16%) are below industry benchmarks, suggesting modest profitability.
  • The company's liquidity position is moderate, with a current ratio of 2.66, but a negative net cash position after subtracting total debt raises concerns.
  • Alufluoride Ltd's revenue is concentrated in a single business segment, increasing its exposure to industry-specific risks.
  • The company's risk profile is characterized by moderate liquidity risk and low dilution risk, with no significant share issuance activity reported.
  • No material events or strategic initiatives have been disclosed in recent filings, indicating a stable but uneventful operational outlook.
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$429.1M
Gross profit$953.0k
Operating income$34.4M
Net income$53.3M
R&D
SG&A
D&A
SBC
Operating cash flow$349.8M
CapEx-$87.3M
Free cash flow
Total assets$1.28B
Total liabilities$437.7M
Total equity$845.3M
Cash & equivalents$8.9M
Long-term debt$251.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$385.0M-$12.2M-$5.5M-$52.8M
FY-3$879.5M$70.3M$35.2M-$271.8M
FY-2$1.36B$194.6M$128.2M$44.3M
FY-1$1.62B$221.8M$176.6M$158.6M
FY0$1.89B$270.5M$180.9M$101.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$954.6M$518.7M$83.2M
FY-3$999.5M$555.7M
FY-2$1.14B$679.8M
FY-1$1.28B$845.3M
FY0$1.48B$1.02B
PeriodOCFCapExFCFSBC
FY-4-$22.4M-$72.4M-$52.8M
FY-3$36.6M-$370.5M-$271.8M
FY-2$202.1M-$154.7M$44.3M
FY-1$349.8M-$87.3M$158.6M
FY0$120.8M-$145.2M$101.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$429.1M$34.4M$53.3M
FQ-6$337.1M$53.5M$38.0M
FQ-5$532.0M$83.1M$66.5M
FQ-4$476.0M$83.5M$60.5M
FQ-3$540.1M$25.9M$15.9M
FQ-2$437.6M$48.8M$31.0M
FQ-1$548.3M$115.5M$79.3M
FQ0$585.9M$116.2M$94.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.28B$845.3M$8.9M
FQ-6
FQ-5$1.34B$943.3M$12.8M
FQ-4
FQ-3$1.48B$1.02B$24.2M
FQ-2
FQ-1$1.64B$1.12B$29.1M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$349.8M-$87.3M
FQ-6
FQ-5$133.7M-$54.6M
FQ-4
FQ-3$120.8M-$145.2M
FQ-2
FQ-1$240.5M-$146.5M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$845.3M
Net cash-$242.5M
Current ratio2.7
Debt/Equity0.3
ROA4.2%
ROE6.3%
Cash conversion6.6%
CapEx/Revenue-20.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricALUFActivity
Op margin8.0%5.5% medp25 -0.0% · p75 10.8%above median
Net margin12.4%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin0.2%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-20.3%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity30.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:58 UTC#ac41d16a
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:27 UTCJob: 3e599546